Maravai LifeSciences Holdings, Inc. Restructuring Costs
Maravai LifeSciences Holdings, Inc. (MRVI) reported Restructuring Costs of -$33.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. restructuring costs for the quarter ending 2026-06-30 was -$33.00K.
- Maravai LifeSciences Holdings, Inc. restructuring costs for the quarter ending 2026-03-31 was $3.11M.
- Maravai LifeSciences Holdings, Inc. restructuring costs for the quarter ending 2025-12-31 was $15.13M, a 151220.00% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. restructuring costs for the quarter ending 2025-09-30 was $6.93M.
- Maravai LifeSciences Holdings, Inc. restructuring costs for fiscal 2025 was $22.06M, a 200481.82% increase from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. restructuring costs for fiscal 2024 was $11.00K, a 99.83% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. restructuring costs for fiscal 2023 was $6.57M.
- Maravai LifeSciences Holdings, Inc. restructuring costs for fiscal 2022 was $0.00.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.00K 10-Q · filed 2026-08-07 | $3.08M 10-Q · filed 2026-08-07 | $18.21M derived: sum of 3 quarters · filed 2026-08-07 | $25.14M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.11M 10-Q · filed 2026-05-08 | $18.24M derived: sum of 2 quarters · filed 2026-05-08 | $25.17M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2025-12-31 | $15.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.06M derived: sum of 2 quarters · filed 2026-02-26 | $22.06M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $6.93M 10-Q · filed 2025-11-07 | $6.93M 10-Q · filed 2025-11-07 | ||
| 2024-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$8.00K derived: sum of 3 quarters · filed 2026-02-26 | $11.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$10.00K 10-Q · filed 2025-11-07 | -$18.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.00K 10-Q · filed 2025-11-07 | $6.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$8.00K 10-Q · filed 2025-08-11 | $11.00K 10-Q · filed 2025-08-11 | $6.58M derived: sum of 3 quarters · filed 2026-02-26 | $6.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $19.00K 10-Q · filed 2025-05-12 | $6.59M derived: sum of 2 quarters · filed 2026-02-26 | $6.59M derived: sum of 3 quarters · filed 2026-02-26 | $6.59M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $6.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.57M derived: sum of 2 quarters · filed 2026-02-26 | $6.57M derived: sum of 3 quarters · filed 2026-02-26 | $6.57M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |